Albert G.  White, III net worth and biography

Albert White, III Biography and Net Worth

Mr. White has served as President & Chief Executive Officer and a member on our Board of Directors since May 2018. Previously, he served as Chief Financial Officer from November 2016 until his appointment as CEO and he also served as Executive Vice President and Chief Strategy Officer, positions he held from December 2015 and July 2011, respectively. From August 2015 to May 2018, Mr. White also directed our women’s healthcare business and served as Chief Executive Officer of Cooper Medical Inc., the parent company to CooperSurgical. Previously, he served as Vice President, Investor Relations from November 2007 through March 2013 and as Vice President and Treasurer from April 2006 through December 2012. Prior to joining the Company, Mr. White was a Director with KeyBanc Capital Markets for three years and held a number of leadership positions within KeyBank National Association over the prior eight years.

What is Albert G. White, III's net worth?

The estimated net worth of Albert G. White, III is at least $15.44 million as of September 19th, 2024. Mr. White, III owns 165,273 shares of Cooper Companies stock worth more than $15,443,109 as of December 21st. This net worth estimate does not reflect any other investments that Mr. White, III may own. Learn More about Albert G. White, III's net worth.

How do I contact Albert G. White, III?

The corporate mailing address for Mr. White, III and other Cooper Companies executives is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. Cooper Companies can also be reached via phone at (925) 460-3600 and via email at [email protected]. Learn More on Albert G. White, III's contact information.

Has Albert G. White, III been buying or selling shares of Cooper Companies?

Albert G. White, III has not been actively trading shares of Cooper Companies over the course of the past ninety days. Most recently, Albert G. White III sold 114,992 shares of the business's stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $110.53, for a transaction totalling $12,710,065.76. Following the completion of the sale, the chief executive officer now directly owns 165,273 shares of the company's stock, valued at $18,267,624.69. Learn More on Albert G. White, III's trading history.

Who are Cooper Companies' active insiders?

Cooper Companies' insider roster includes Brian Andrews (CFO), Robert Auerbach (CEO), Jody Lindell (Director), Daniel McBride (COO), Gary Petersmeyer (Director), Agostino Ricupati (SVP), Holly Sheffield (EVP), Gerard Warner, III (COO), Robert Weiss (Director), and Albert White, III (CEO). Learn More on Cooper Companies' active insiders.

Are insiders buying or selling shares of Cooper Companies?

In the last year, insiders at the medical device company sold shares 7 times. They sold a total of 312,697 shares worth more than $33,312,446.01. The most recent insider tranaction occured on September, 19th when CEO Albert G White III sold 114,992 shares worth more than $12,710,065.76. Insiders at Cooper Companies own 2.0% of the company. Learn More about insider trades at Cooper Companies.

Information on this page was last updated on 9/19/2024.

Albert G. White, III Insider Trading History at Cooper Companies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/19/2024Sell114,992$110.53$12,710,065.76165,273View SEC Filing Icon  
3/8/2021Sell318,980$97.16$30,990,501.90195,868View SEC Filing Icon  
7/8/2020Buy4,000$69.56$278,230.00165,720View SEC Filing Icon  
9/14/2016Sell80,000$46.43$3,714,400.00166,556View SEC Filing Icon  
3/10/2015Sell25,500$45.74$1,166,433.75View SEC Filing Icon  
7/15/2014Sell63,920$37.72$2,411,222.20View SEC Filing Icon  
6/18/2013Sell86,080$30.86$2,656,428.80View SEC Filing Icon  
See Full Table

Albert G. White, III Buying and Selling Activity at Cooper Companies

This chart shows Albert G White III's buying and selling at Cooper Companies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cooper Companies Company Overview

Cooper Companies logo
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Read More

Today's Range

Now: $93.44
Low: $92.28
High: $94.71

50 Day Range

MA: $102.46
Low: $91.93
High: $108.56

2 Week Range

Now: $93.44
Low: $84.76
High: $112.38

Volume

2,784,859 shs

Average Volume

1,180,332 shs

Market Capitalization

$18.65 billion

P/E Ratio

47.92

Dividend Yield

N/A

Beta

0.97